氟化镁

常用名 氟化镁 英文名 Magnesium Fluoride
CAS号 7783-40-6 分子量 62.302
密度 3.15 沸点 2260ºC
分子式 F2Mg 熔点 1248ºC
MSDS氟化镁的MSDS|SDS|pdf下载 中文版 美版 闪点 N/A

 氟化镁用途


1.用作冶炼金属镁的助熔剂、电解铝的添加剂、光学透镜镀膜、钛颜料的涂着剂、阴极射线屏的荧光材料。也用于陶瓷、玻璃工业。 2.用于光学透镜镀膜、光学玻璃和陶瓷工业。用作光谱试剂。
3. 制造陶瓷、玻璃及冶炼镁、铝金属的助熔剂,光学仪器中镜头及滤光器的涂层。阴极射线屏的荧光材料、光学透镜的反折射剂及焊接剂。钛颜料的涂着剂。

 氟化镁名称

[ 中文名 ]: 氟化镁
[ 英文名 ]: Magnesium Fluoride
[英文别名 ]: MFCD00011108
Magnesium fluoride
EINECS 231-995-1

 氟化镁物理化学性质

[ 密度 ]: 3.15
[ 沸点 ]: 2260ºC
[ 熔点 ]: 1248ºC
[ 分子式 ]: F2Mg
[ 分子量 ]: 62.302
[ 精确质量 ]: 61.981850
[ LogP ]: 0.84040
[ 外观性状 ]: 白色至淡米色粉末
[ 折射率 ]: 1.365
[ 储存条件 ]:

保持贮藏器密封

放入紧密的贮藏器内,储存在阴凉,干燥的地方。

[ 稳定性 ]:

在电光下加热呈弱紫色荧光,其晶体具有良好的偏振作用,特别适于紫外和红外光谱。在100g水的溶解度为0.013g(25℃)。微溶于稀酸,易溶于硝酸。

[ 计算化学 ]:

1、 疏水参数计算参考值(XlogP):

2、 氢键供体数量:0

3、 氢键受体数量:2

4、 可旋转化学键数量:0

5、 互变异构体数量:

6、 拓扑分子极性表面积(TPSA):0

7、 重原子数量:3

8、 表面电荷:0

9、 复杂度:2.8

10、 同位素原子数量:0

11、 确定原子立构中心数量:0

12、 不确定原子立构中心数量:0

13、 确定化学键立构中心数量:0

14、 不确定化学键立构中心数量:0

15、 共价键单元数量:3

[ 更多 ]:

1. 性状:无色结晶,金红石型结构。无味。在灯光下带有紫色荧光。

2. 密度(g/mL 25ºC):3.148

3. 熔点(ºC):1248

4. 沸点(ºC,常压):2263

5. 折射率(n20/D):1.365

6. 溶解性(mg/mL):能溶于硝酸,微溶于稀酸,难溶于水和醇。

 氟化镁MSDS

Name: Magnesium Fluoride 98+% Material Safety Data Sheet
Synonym: Afluon; Irtran 1; Magnesium fluorure; Sellait
CAS: 7783-40-6
Section 1 - Chemical Product MSDS Name:Magnesium Fluoride 98+% Material Safety Data Sheet
Synonym:Afluon; Irtran 1; Magnesium fluorure; Sellait

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
7783-40-6 Magnesium fluoride, 99.999% 231-995-1
Hazard Symbols: None Listed.
Risk Phrases: None Listed.

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract.
Inhalation:
May cause respiratory tract irritation.
Chronic:
No information found.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective Equipment section. Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Keep container closed when not in use. Store in a cool, dry, well-ventilated area away from incompatible substances.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits.
Exposure Limits CAS# 7783-40-6: United Kingdom, WEL - TWA: (listed as fluorides, inorganic): 2.5 mg/m3 TWA (as F) United Kingdom, WEL - STEL: (listed as fluorides, inorganic): 6.2 mg/m3 STEL (as F) United States OSHA: 2.5 mg/m3 TWA (as F) (listed under Fluorides).2.5 mg/m3 TWA (as F) (listed under Fluorides).
Belgium - TWA: (listed as fluorides, inorganic): 2.5 mg/m3 VLE (a France - VME: (listed as fluorides): 2.5 mg/m3 VME (as F) Germany: (listed as fluorides): 2.5 mg/m3 VME (as F) Malaysia: (listed as fluorides): 2.5 mg/m3 TWA (as F) Netherlands: (listed as fluorides): 3.5 mg/m3 STEL (as F) Russia: 2.5 mg/m3 TWA Russia: 0.5 mg/m3 STEL Spain: (listed as fluorides, inorganic): 2.5 mg/m3 VLA-ED (except uranium hexafluoride, as F) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: None reported.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 2239 deg C @ 760.00mmHg
Freezing/Melting Point: 1263 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Slightly soluble.
Specific Gravity/Density:
Molecular Formula: F2Mg
Molecular Weight: 62.31

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, fluoride fumes.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 7783-40-6: OM3325000 LD50/LC50:
CAS# 7783-40-6: Oral, rat: LD50 = 2330 mg/kg.
Carcinogenicity:
Magnesium fluoride, 99.999% - Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 7783-40-6: 1
Canada
CAS# 7783-40-6 is listed on Canada's DSL List.
CAS# 7783-40-6 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7783-40-6 is listed on the TSCA inventory.


SECTION 16 - ADDITIONAL INFORMATION
N/A

 氟化镁毒性和生态

氟化镁毒理学数据:

豚鼠经口LD:1000mg/kg、肌肉注射3000mg/kg。有毒!吸入或与皮肤接触时有毒害。

氟化镁生态学数据:

对水是稍微危害的,若无政府许可,勿将材料排入周围环境。

CHEMICAL IDENTIFICATION

RTECS NUMBER :
OM3325000
CHEMICAL NAME :
Magnesium fluoride
CAS REGISTRY NUMBER :
7783-40-6
LAST UPDATED :
199712
DATA ITEMS CITED :
31
MOLECULAR FORMULA :
F2-Mg
MOLECULAR WEIGHT :
62.31
WISWESSER LINE NOTATION :
MG F2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
1 gm/kg
REFERENCE :
85KYAH "Merck Index; an Encyclopedia of Chemicals, Drugs, and Biologicals", 11th ed., Rahway, NJ 07065, Merck & Co., Inc. 1989 Volume(issue)/page/year: 11,892,1989 *** REVIEWS *** ACGIH TLV-TWA 2.5 mg(F)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-Not classifiable as a human carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 TOXICOLOGY REVIEW AMSSAQ Acta Medica Scandinavica, Supplement. (Almqvist & Wiksell, POB 45150, S-10430 Stockholm, Sweden) No.1-730, 1921-88. Volume(issue)/page/year: 400,5,1963 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 2.5 mg(F)/m3 DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,116,1971 OSHA PEL (Gen Indu):8H TWA 2.5 mg(F)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 2.5 mg(F)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 2.5 mg(F)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):8H TWA 2.5 mg(F)/m3 CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 2.5 mg(F)/m3 JAN 1993 OEL-BELGIUM:TWA 2.5 mg(F)/m3 JAN 1993 OEL-DENMARK:TWA 2.5 mg(F)/m3 JAN 1993 OEL-FINLAND:TWA 2.5 mg(F)/m3 JAN 1993 OEL-FRANCE:TWA 2.5 mg(F)/m3 JAN 1993 OEL-GERMANY:TWA 2.5 mg(F)/m3 JAN 1993 OEL-HUNGARY:TWA 1 mg(F)/m3;STEL 2 mg(F)/m3 JAN 1993 OEL-THE NETHERLANDS:TWA 2.5 mg(F)/m3 JAN 1993 OEL-THE PHILIPPINES:TWA 2.5 mg(F)/m3 JAN 1993 OEL-POLAND:TWA 1 mg(F)/m3 JAN 1993 OEL-RUSSIA:TWA 0.5 mg/m3;STEL 2.5 mg/m3 JAN 1993 OEL-SWEDEN:TWA 2 mg(F)/m3 JAN 1993 OEL-SWITZERLAND:TWA 1.8 ppm (1.5 mg(F)/m3);STEL 9.0 ppm JAN 1993 OEL-THAILAND:TWA 2.5 mg(F)/m3 JAN 1993 OEL-TURKEY:TWA 2.5 mg(F)/m3 JAN 1993 OEL-UNITED KINGDOM:TWA 2.5 mg(F)/m3 JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO FLUORIDES, INORGANIC-air:10H TWA 2.5 mg(F)/m3 REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992 NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80297 No. of Facilities: 30 (estimated) No. of Industries: 3 No. of Occupations: 2 No. of Employees: 135 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 80297 No. of Facilities: 266 (estimated) No. of Industries: 9 No. of Occupations: 10 No. of Employees: 2048 (estimated) No. of Female Employees: 256 (estimated)

 氟化镁安全信息

[ 个人防护装备 ]: dust mask type N95 (US);Eyeshields;Gloves
[ 危害码 (欧洲) ]: Xi:Irritant
[ 风险声明 (欧洲) ]: R36/37/38
[ 安全声明 (欧洲) ]: S26-S37/39
[ 危险品运输编码 ]: NONH for all modes of transport
[ WGK德国 ]: 3
[ RTECS号 ]: OM3325000
[ 海关编码 ]: 2826199090

 氟化镁制备

1.碳酸镁法 在衬铅的反应器中,盛有过量的氢氟酸,在搅拌下加入菱镁矿矿浆,于90~95℃下进行反应。反应生成的氟化镁,经过滤、洗涤、在105℃左右进行干燥,再经粉碎,制得氟化镁成品。其反应方程式如下:
7783-40-6 preparation
2.用一定量的电导水与99.99%的高纯氧化酶混合,用塑料棒搅拌成糊状,然后慢慢加入高纯氢氟酸(稍过量),搅拌后在水浴中煮5-6h,并不断搅拌。待氧化酶全部转化为氟化镁时,用煮沸的电导水倾析法洗涤两次,吸滤后,沉淀置于铂皿中于电炉上灼烧,不时搅拌,干燥后即得高纯氟化镁。 3.碳酸镁与氢氟酸反应。在聚乙烯烧杯中装入50g 46%的氢氟酸,加入42g水稀释为25%的氢氟酸。将烧杯放在冰水浴中冷却,边搅拌边加入48g碳酸镁,即有氟化镁沉淀产生,脱水后,于400℃干燥,所得氟化镁35g
3. 氟化镁的制法由于所用镁盐的不同而分为(1)碳酸镁法 系用氢氟酸与碳酸镁来制取;(2)氧化镁法 系用氢氟酸与氧化镁反应而得;(3)硫酸镁法 系用氟化钠与硫酸镁反应制得,也可用硫酸镁水溶液和氢氟酸(20%)反应而得。在衬铅的反应器中,盛有过量的氢氟酸(40%),在搅拌下加入200目菱镁矿粉熔于其中,于90℃反应30min,其反应式如下。
7783-40-6 preparation 反应生成的氟化镁,经过滤、洗涤,并在105℃左右进行干燥,再经粉碎后即得成品。

 氟化镁海关

[ 海关编码 ]: 2826199090

 氟化镁文献28

更多文献
Comparison of the Biological Impacts of the Fluoride Compounds by Graphical Risk Visualization Map Technique.

Biol. Trace Elem. Res. 167 , 84-90, (2015)

Various fluoride compounds are widely used in industry. The present risk assessment study was conducted using a series of inorganic binary fluorides of the type XFn, where X(n) = Na(+), K(+), Li(+), M...

Differentiating sepsis from non-infectious systemic inflammation based on microvesicle-bacteria aggregation.

Nanoscale 7 , 13511-20, (2015)

Sepsis is a severe medical condition and a leading cause of hospital mortality. Prompt diagnosis and early treatment has a significant, positive impact on patient outcome. However, sepsis is not alway...

Machinable glass-ceramics forming as a restorative dental material.

Dent. Mater. J. 30(3) , 358-67, (2011)

MgO, SiO(2), Al(2)O(3), MgF(2), CaF(2), CaCO(3), SrCO(3), and P(2)O(5) were used to prepare glass-ceramics for restorative dental materials. Thermal properties, phases, microstructures and hardness we...